NOT-HL-24-020: Notice of Early Expiration and Reissuance of NOT-HL-22-039 "Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects"

Notice of Early Expiration and Reissuance of NOT-HL-22-039 "Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects"

Notice Number:

NOT-HL-24-020

Key Dates

Release Date:

June 28, 2024

Related Announcements

June 26, 2024 - Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects (SRPs). See NOSI NOT-HL-24-007.
January 11, 2023 - Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed). See NOFO RFA-HL-24-004.
January 11, 2023 - Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Core (U24 Clinical Trial Not Allowed). See NOFO RFA-HL-24-003.
October 9, 2020 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional). See NOFO PA-20-272.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice is to inform the research community of the early expiration of NOT-HL-22-039 "Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects" effective immediately. NHLBI has reissued the NOSI as NOT-HL-24-007 "Notice of Special Interest (NOSI): Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects (SRPs)" with updated content, first due date, and expiration date. Potential applicants are advised to review NOT-HL-24-007 for essential information.

In summary:

The expired NOSI, effective immediately, is NOT-HL-22-039.
The reissued NOSI is NOT-HL-24-007 (First Available Due Date: August 01, 2024, Expiration Date: December 02, 2027).

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Nicole Redmond, MD, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0379
Email: [email protected]

Financial/Grants Management Contact(s)

Chantal Falade, MBA
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-5870
Email: [email protected]